Currently the price is 1,88$, Jounce Therapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Dmitri Wiederschain (Chief Scientific Officer), Elizabeth G. Trehu (Chief Medical Officer), Hugh M. Cole (Chief Business Officer & Head-Development), Kimberlee Cobleigh Drapkin (Chief Financial Officer & Treasurer), Richard Murray (President, Chief Executive Officer & Director), Stephen Farrand (Chief Technical Officer) and its address is 780 MEMORIAL DRIVE, CAMBRIDGE, Massachusetts, 2139, United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 1,88$ - 1,93$, with a percentage difference of 1,91$ quite wide that helps to be able to do day trading.
He earns an annual income of desconocido.
The opening price that appears as last recorded is desconocido.
To detect if it is a good time to enter or exit a stock, many traders use the lowest and highest values of the last 52 weeks. In this action, prices have moved between 0,00$ and 0,00$.
Earnings per share, or EPS, is a value also used to assess whether a company has obtained sufficient net profits for the number of shares it has for sale. In this case it is [BPA], but it must be taken into account that there may have been increases or decreases in capital that influence the value.
Buscar
